<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

qz
After Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Maze Therapeutics, Inc. (MAZE)

The heavy selling pressure might have exhausted for Maze Therapeutics, Inc. (MAZE) as it is technically in oversold territory now. In addition to this technical [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
How to trace a picture's origin with reverse image search

Reverse image searching is a quick and easy way to trace the origin of an image, identify objects or landmarks, find higher-resolution alternatives or check if a photo has been altered or used elsewhe [...]

Match Score: 118.48

Destination
How to perform a reverse phone number lookup

In an age of constant communication, receiving phone calls or messages from unknown numbers has become increasingly common. Whether it's a missed call from an unfamiliar number, a potential scam [...]

Match Score: 102.29

thenextweb
Cambridge biotech STORM Therapeutics raises $56M

STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by e [...]

Match Score: 50.61

qz
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?

Dianthus Therapeutics, Inc. (DNTH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions [...]

Match Score: 48.63

qz
After Plunging 12.7% in 4 Weeks, Here's Why the Trend Might Reverse for Maximus (MMS)

The heavy selling pressure might have exhausted for Maximus (MMS) as it is technically in oversold territory now. In addition to this technical measure, strong [...]

Match Score: 46.31

qz
After Plunging 34% in 4 Weeks, Here's Why the Trend Might Reverse for Progress Software (PRGS)

Progress Software (PRGS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wa [...]

Match Score: 46.31

qz
After Plunging 17.7% in 4 Weeks, Here's Why the Trend Might Reverse for OppFi (OPFI)

OppFi (OPFI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement am [...]

Match Score: 45.54

qz
After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)

InspireMD (NSPR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreemen [...]

Match Score: 45.54

Destination
Viking Therapeutics closer to bringing its Ozempic competitor to market

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm.Read more... [...]

Match Score: 40.48